Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12613000910707
ACTRN12613000910707
Completed
N/A

Effect of Baclofen sustained release vs placebo on alleviation of reflux symptoms in patients with Gastroesophageal reflux disease

Shahid Beheshti University of Medical Sciences0 sites40 target enrollmentAugust 15, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 15, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •patients with diagnosis of Gastroesophageal reflux disease on the basis of Rome 3 criteria

Exclusion Criteria

  • •1\.history of Hypersensivity to baclofen
  • •2\.renal or hepatic failure
  • •3\.Neurological diseases
  • •4\.pregnant women
  • •5\.breastfeeding women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
The effect of baclofen on methamphetamine dependent subjects.Methamphetamine AddictionMental Health - AddictionNeurological - Other neurological disorders
ACTRN12616001614482inear Clinical Research Ltd18
Not Yet Recruiting
Phase 3
A pilot investigation of the effects of Baclofen on a quantitative electroencephalographic predictor of relapse to alcohol dependence.Alcohol Use DisorderMental Health - Other mental health disorders
ACTRN12613000372785Royal Adelaide Hospital20
Not Yet Recruiting
Phase 4
A study to compare whether oral baclofen or oral tizanidine is better in patients presenting with tightness of the upper limb after stroke.Health Condition 1: G811- Spastic hemiplegia
CTRI/2024/03/064651Jalpaiguri Government Medical College and Hospital
Active, Not Recruiting
N/A
A placebo controlled trial with Baclofen for the treatment of GERD patients with incomplete PPI responseGastroesophageal reflux disease
EUCTR2009-017351-96-BEZleuven
Active, Not Recruiting
Phase 1
Study investigating the effect of baclofen in patients with postprandial regurgitation or belchingRumination syndrome and supragastric belchingMedDRA version: 14.0Level: LLTClassification code 10039292Term: Rumination disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.0Level: LLTClassification code 10004222Term: BelchingSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2011-002745-35-BEZLeuven20